The old adage, prostate cancer is the cancer that you die with not the cancer you die from has been around for a long time. No question compared too many other cancers prostate cancer does progress more slowly than many other cancers. But, is this adage true? Men with prostate cancer have competing mortality risks [...]
There has been a lot of criticism about the recent guidelines on PSA testing that has been issued by the American Cancer Society (ACS). Many of us with advanced prostate cancer are appalled with these guidelines and feel it is just another example of the ACS abandoning men with cancer over the powerful breast cancer [...]
The House Committee on Oversight and Government Reform, chaired by Congressman Edolphus Towns, will hold a hearing entitled: “Prostate Cancer: New Questions About Screening and Treatment” tomorrow, Thursday, March 4, 2010 at 10:00 a.m. This is the first Congressional prostate cancer hearing in 11 years and, in the midst of debate on a health reform [...]
A Gleason Score of 7 is often looked at as a middle range score, but clearly not as serious as an 8 or 9 score. Some recently combined research performed at the Department of Urology, University of Washington School of Public Health, Seattle, Washington and the Division of Public Health Sciences, Fred Hutchinson Cancer Research [...]
David P. Wood, Jr., MD gave a presentation at the 9th International Prostate Forum (IPF) on October 8 - 10, 2009 in Izmir, Turkey on the Management the side effects of hormone therapy (ADT) when used to treat of prostate cancer. Dr. Wood indicated that the three major side effects of ADT in the treatment [...]